Notícias e Atividades da AC Immune

AC Immune é uma empresa listada sob o símbolo ACIU (CH).

Veja o organograma con seus 20 executivos principais

Biografias mais buscadas da AC Immune

• Martin Zügel, Chairman of the Board and Interim Chief Executive O...
• Roy Twyman, Director
• Carl June, Director

Recentes movimentos de executivos em AC Immune

• Martin Zügel antes Chairman of the Board and Director, agora é Chairman of the Board and Interim Chief Executive Officer  (Notícia publicada em 12 de maio de 2026).
• Andrea Pfeifer, Chief Executive Officer and Director, deixou a Companhia  (Notícia publicada em 12 de maio de 2026).

Criar um alerta
para seguir os movimentos de executivos da AC Immune.

AC Immune possui 2.429 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Patrick Enright - Director da CuraSen Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de AC Immune

• Detailed Data From the Phase II Crenezumab Alzheimer’s Prevention Initiative Study in Autosomal Dominant Alzheimer’s Disease Presented at AAIC | AC Immune SA
• AC Immune Reports Second Quarter 2022 Financial Results and Provides Corporate Update | AC Immune SA
• AC Immune Announces Upcoming Presentations at the Alzheimer’s Association International Conference | AC Immune SA
• AC Immune Holds Annual General Meeting of Shareholders | AC Immune SA
• AC Immune Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease | AC Immune SA
• AC Immune to Present at the 2022 Jefferies Healthcare Conference | AC Immune SA
• AC Immune CEO Andrea Pfeifer Receives Aenne Burda Award | AC Immune SA
• AC Immune’s Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology | AC Immune SA
• AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update | AC Immune SA
• AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference | AC Immune SA
• View more press releases Close

Redes sociais sobre AC Immune

• AC Immune na Wikipedia, Google News e Yahoo Finance
• AC Immune na LinkedIn, X (Twitter) e YouTube